Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-03-31FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Northstar RxLLC)
FDA approved Northstar RxLLC's Original Application for hydroxyzine hydrochloride, a generic antihistamine product.
-
FDA approval · 2008-03-25FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)
The FDA approved a supplemental application for Cordran (flurandrenolide) from INA Pharmaceutics, Inc.
-
FDA approval · 2007-09-04FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic topical product combining nystatin and triamcinolone acetonide (Sun Pharmaceutical…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved the original application for Betamethasone Dipropionate (a generic topical corticosteroid) from E. Fougera & Co., marking appro…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic topical corticosteroid, Betamethasone Dipropionate, under Sun Pharmaceutical Industries' Original Application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-08-28FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Diprolene (betamethasone dipropionate) submitted by Organon LLC, resulting in updated labeling f…
-
FDA approval · 2006-08-14FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under th…